Both in Biotechnology
Greenland Mines vs Cardiff Oncology
Over the past year GRML returned +32.7% and CRDF returned −28.7%; their daily moves had a correlation of 0.08.
GRML +32.7% CRDF −28.7%Growth of $1, one year, split-adjusted
| Metric | GRML | CRDF |
|---|---|---|
| Price | $4.18 | $0.8631 |
| Market cap | $57.2M | $67.1M |
| Today | +4.76% | +2.23% |
| 1 month | −43.1% | −24.3% |
| 6 months | — | −46.4% |
| Year to date | — | −69.3% |
| 1 year | — | −63.3% |
| Revenue growth (YoY) | — | −14.0% |
| Gross margin | — | 100.0% |
| Net margin | — | −8882.7% |
| P/E (TTM) | — | — |
| Price / sales | — | 132.2× |
| Net cash | $9.3M | $34.5M |
| Dividend yield | — | — |
| Volatility (60d) | — | 71.6% |
| Short % of float | 76.3% | 17.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).